Our top pick for
Chemed Corporation is a medical care facilities business based in the US. Chemed Corporation shares (CHE) are listed on the NYSE and all prices are listed in US Dollars. Chemed Corporation employs 15,544 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$410.66 - $559.57|
|50-day moving average||$463.78|
|200-day moving average||$488.41|
|Wall St. target price||$575.00|
|Dividend yield||$1.34 (0.28%)|
|Earnings per share (TTM)||$20.13|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Chemed Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chemed Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Chemed Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Chemed Corporation shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Chemed Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.66. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chemed Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Chemed Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $367.1 million.
The EBITDA is a measure of a Chemed Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.1 billion|
|Operating margin TTM||15.1%|
|Gross profit TTM||$701.4 million|
|Return on assets TTM||14.42%|
|Return on equity TTM||40.8%|
|Market capitalisation||$7.6 billion|
TTM: trailing 12 months
There are currently 182,737 Chemed Corporation shares held short by investors – that's known as Chemed Corporation's "short interest". This figure is 7% down from 196,510 last month.
There are a few different ways that this level of interest in shorting Chemed Corporation shares can be evaluated.
Chemed Corporation's "short interest ratio" (SIR) is the quantity of Chemed Corporation shares currently shorted divided by the average quantity of Chemed Corporation shares traded daily (recently around 78092.735042735). Chemed Corporation's SIR currently stands at 2.34. In other words for every 100,000 Chemed Corporation shares traded daily on the market, roughly 2340 shares are currently held short.
However Chemed Corporation's short interest can also be evaluated against the total number of Chemed Corporation shares, or, against the total number of tradable Chemed Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chemed Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Chemed Corporation shares in existence, roughly 10 shares are currently held short) or 0.0133% of the tradable shares (for every 100,000 tradable Chemed Corporation shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chemed Corporation.
Find out more about how you can short Chemed Corporation stock.
Dividend payout ratio: 5.95% of net profits
Recently Chemed Corporation has paid out, on average, around 5.95% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Chemed Corporation shareholders could enjoy a 0.29% return on their shares, in the form of dividend payments. In Chemed Corporation's case, that would currently equate to about $1.34 per share.
While Chemed Corporation's payout ratio might seem low, this can signify that Chemed Corporation is investing more in its future growth.
Chemed Corporation's most recent dividend payout was on 18 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 February 2021 (the "ex-dividend date").
Chemed Corporation's shares were split on a 2:1 basis on 11 May 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Chemed Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Chemed Corporation shares which in turn could have impacted Chemed Corporation's share price.
Over the last 12 months, Chemed Corporation's shares have ranged in value from as little as $410.6591 up to $559.5737. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chemed Corporation's is 0.487. This would suggest that Chemed Corporation's shares are less volatile than average (for this exchange).
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio. .
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.